|
 |
|
Slovakia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
 |
|
$2500.00 |
| |
|
|
|
Slovenia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Sweden Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Switzerland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Tumor Markers: Strategic Assessments of Current and Emerging Competitors
This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents....
|
|
|
$2500.00 |
| |
|
|
|
Analysis of the French Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including:
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the German Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including:
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the Italian Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including:
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the Japanese Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including:
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the Spanish Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including:
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the UK Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including:
|
|
|
$2200.00 |
| |
|
|
|
Tumor Marker Diagnostic Technologies: Assessment of Current and Emerging Technologies, And Their Potential Market Applications
This 110-page report provides: - Assessments and potential applications of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry and biosensors or tumor marker diagnostic testing.
- Review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
Contains 110 pages
|
|
|
$1850.00 |
| |
|
|
|
Tumor Marker Testing Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semi-automated Analyzers
This report reviews current instrumentation technologies, and compares features of major automated and semi-automated analyzers used for tumor marker testing. Contains 25 pages
|
|
|
$950.00 |
| |
|
|
|
Tumor Marker Testing: A Global Market Overview--Facilities, Test Volumes, and Sales Forecasts by Country
This report provides: - Worldwide overview of the tumor marker diagnostics market
- Mortality statistics and scientific views on the etiology of major types of cancer.
- Estimates of the number of laboratories performing tumor marker testing....
|
|
|
$950.00 |
| |
|
|
|
Tumor Marker Diagnostics Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks
Highlights - Identifies major opportunities emerging in the tumor marker diagnostics market during the next ten years.
- Proposes "ideal" product models with tentative prices and operating characteristics....
|
|
|
$850.00 |
| |
|
|
|
US Tumor Markers Testing Market: Sales Forecasts By Market Segment and Supplier Shares by Test
This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$850.00 |
| |
|
|
|
France Tumor Markers Testing Market: Sales Forecasts By Market Segment and Supplier Shares by Test
This report provides an overview of the French cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
Germany Tumor Markers Testing Market: Sales Forecasts By Market Segment and Supplier Shares by Test
This report provides an overview of the German cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
|